Robust models of disease heterogeneity and control, with application to the SARS-CoV-2 epidemic.

In light of the continuing emergence of new SARS-CoV-2 variants and vaccines, we create a robust simulation framework for exploring possible infection trajectories under various scenarios. The situations of primary interest involve the interaction between three components: vaccination campaigns, non-pharmaceutical interventions (NPIs), and the emergence of new SARS-CoV-2 variants. Additionally, immunity waning and vaccine boosters are modeled to account for their growing importance.

Disease momentum: Estimating the reproduction number in the presence of superspreading.

A primary quantity of interest in the study of infectious diseases is the average number of new infections that an infected person produces. This so-called reproduction number has significant implications for the disease progression. There has been increasing literature suggesting that superspreading, the significant variability in number of new infections caused by individuals, plays an important role in the spread of SARS-CoV-2.